CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 7, August 2012
370
AFRICA
M, Flather MD,
et al
. From guidelines to clinical practice: the impact
of hospital and geographical characteristics on temporal trends in the
management of acute coronary syndromes.The Global Registry ofAcute
Coronary Events (GRACE).
Eur Heart J
2003;
24
(15): 1414–1424.
4.
Patel MR, Chen AY, Roe MT, Ohman EM, Newby LK, Harrington
RA,
et al.
A comparison of acute coronary syndrome care at academic
and nonacademic hospitals.
Am J Med
2007;
120
(1): 40–46.
5.
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil
U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of
cardioprotective drug therapies in coronary patients from 22 European
countries.
Eur J Cardiovasc Prev Rehabil
2009;
16
(2): 121–137.
6.
Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E,
et al.
A prospective survey of the characteristics, treatments and
outcomes of patients with acute coronary syndromes in Europe and
the Mediterranean basin; the Euro Heart Survey of Acute Coronary
Syndromes (Euro Heart Survey ACS).
Eur Heart J
2002;
23
(15):
1190–1201.
7.
Yusuf S, Hawken S, Ounpuu S, on behalf of the INTERHEART study
investigators. Effect of potentially modifiable risk factors associated
with myocardial infarction in 52 countries (the INTERHEART study):
case-control study.
Lancet
2004;
364
: 937–952.
8.
Waxman A. Prevention of chronic diseases: WHO global strategy on
diet, physical activity and health.
Food Nutr Bull
2003;
24
(3): 281–284.
9.
The ACCESS investigators. Management of acute coronary syndromes
in developing countries: ACute Coronary Events – a multinational
Survey of current management Strategies.
Am Heart J
2011;
162
:
852–859. e22.
10. The Clopidogrel in Unstable Angina to Prevent Recurrent Events trial
investigators. Effects of clopidogrel in addition to aspirin in patients
with acute coronary syndromes without ST-Segment elevations.
N Engl
J Med
2001;
345
: 494–502.
11. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos
G,
et al
. The second Euro Heart Survey on acute coronary syndromes:
Characteristics, treatment, and outcome of patients with ACS in Europe
and the Mediterranean Basin in 2004.
Eur Heart J
2006;
27
(19):
2285–2293.
12. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O,
et al
.
Management of acute coronary syndromes. Variations in practice and
outcome; findings from the Global Registry of Acute Coronary Events
(GRACE).
Eur Heart J
2002;
23
(15): 1177–1189.
13. Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA,
et al.
Global patterns of use of antithrombotic and antiplatelet therapies
in patients with acute coronary syndromes: insights from the Global
Registry of Acute Coronary Events (GRACE).
Am Heart J
2003;
146
(6): 999–1006.
14. Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD,
et al.
Baseline characteristics, management practices, and in-hospital
outcomes of patients hospitalized with acute coronary syndromes in
the Global Registry of Acute Coronary Events (GRACE).
Am J Cardiol
2002;
90
(4): 358–363.
15. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, van de
Werf F,
et al
. A validated prediction model for all forms of acute coro-
nary syndrome: estimating the risk of 6-month postdischarge death in
an international registry.
J Am Med Assoc
2004;
291
(22): 2727–2733.
16. Ohman EM, Roe MT, Smith SC (Jr), Brindis RG, Christenson RH,
Harrington RA,
et al.
Care of non-ST-segment elevation patients:
insights from the CRUSADE national quality improvement initiative.
Am Heart J
2004;
148
(5 Suppl): S34–39.
17. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS,
et al.
Treatment and outcomes of acute coronary syndromes in India
(CREATE): a prospective analysis of registry data.
Lancet
2008;
371
(9622): 1435–1442.
Contact
:
BP
: 6003 Dakar
Tél
: (221) 33 821 55 21
(221) 33 889 38 00 Poste : 3900
Fax
: (221) 33 822 47 46
Mail
:
DAKAR
